A study by Srivastava et al. [12] has previously evaluated plasma biomarkers across diverse kidney diseases and found that sTNFR1, sTNFR2, YKL-40 MCP-1, and suPAR are associated with various kidney diseases like proliferative glomerulonephritis, non-proliferative glomerulopathy, advanced glomerulosclerosis, and diabetic kidney diseases, but the study has not evaluated the plasma biomarkers with MVI in kidney transplant recipients. Here, CCL2 is linked to diabetic kidney disease.